The cash will allow Aventamed to seek regulatory approvals to sell its Solo earplant device in the US, having already launched in European markets.

Ireland-based medtech developer Aventamed, a spinout from Cork Institute of Technology (CIT), received a €1.8m ($2.1m) investment today backed by Irish government-owned enterprise support agencyy Enterprise Ireland.

The round was led by angel syndicate Halo Business Angel Network (HBan), with assorted individual investors from independent angels and affiliates of three HBan syndicates – HBan Medtech Syndicate, Boole Investment Syndicate and Irrus Investments – providing €1.6m.

Enterprise Ireland operates HBan alongside InterTradeIreland, a trade board owned by the Irish state and…